ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Prehabilitation for cancer surgery: perspectives of Australian patients, families, and health professionals.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prehabilitation in thoracic surgery: strong signal or surgical confounding?Journal of thoracic disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeMultimodal prehabilitation prior to major surgery is becoming an expected component of comprehensive, quality cancer care. Participation and adherence remain low, and few health services offer it as usual care. Our aim was to explore stakeholder perspectives, enablers, and barriers to participation in a multimodal prehabilitation programme before cancer surgery.
methodsAn exploratory cross-sectional survey was conducted from July to October 2022 with questions about perspectives towards prehabilitation, and barriers and enablers to participation. Participants who had surgery (i.e. tumour resection) as part of their cancer treatment, their family members, and health professionals at a South Australian tertiary hospital were recruited. Descriptive statistics were used to analyse the data.
resultsPatients (n = 80), their family members (n = 33), and health professionals (n = 37) held positive perceptions towards prehabilitation. Key enablers were the recommendations for multimodal prehabilitation from their surgeon and oncologist (patients n = 46, 58%; family members n = 20, 61%) and the belief it may improve recovery after surgery (n = 41, 51% patients; n = 17, 52% family members). Travel, lack of awareness of benefits, and symptoms were identified as barriers.
conclusionsPrehabilitation was perceived positively, however, access and logistical barriers need to be addressed. Awareness of the benefits of prehabilitation, recommendations from medical staff, and flexible programme delivery are key recommendations. IMPLICATIONS FOR CANCER SURVIVORS: To engage patients undergoing surgery for cancer, there are tangible enablers that should be harnessed and barriers that need to be overcome to increase the uptake of multimodal prehabilitation. Clear and consistent information, and access to such programmes, should be seen as a priority.
Indexed as
Identifiers
41288756What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.